Troglitazone reverses the inhibition of nitric oxide production by high glucose in cultured bovine retinal pericytes

Experimental Eye Research

Volumn 81, Issue 1, 2005, Pages 65-70

  Kim, Jaetaek ^a,b   Oh, Yeon Sahng ^a   Shinn, Soon Hyun ^a  

^a Chung Ang University   (South Korea)

^b Chung Ang University College of Medicine   (South Korea)

Author keywords

High glucose; iNOS; Nitric oxide; Retinal pericytes; Troglitazone

Indexed keywords

GLUCOSE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; TROGLITAZONE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA CELL; SYNTHESIS;

ANIMALS; BLOTTING, WESTERN; CATTLE; CELLS, CULTURED; CHROMANS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; HYPOGLYCEMIC AGENTS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PERICYTES; PPAR GAMMA; RETINA; THIAZOLIDINEDIONES;

EID: 20544434995     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2005.01.010     Document Type: Article

References (44)

1. Y. Aizawa, J. Kawabe, N. Hasebe, N. Takehara, and K. Kikuchi Pioglitazone enhances cytokine-induced apoptosis in vascular smooth muscle cells and reduces intimal hyperplasia Circulation 104 2001 455 460
2. F. Aktan iNOS-mediated nitric oxide production and its regulation Life Sci. 75 2004 639 653
3. A. Antonelli-Orlidge, S.R. Smith, and P.A. D'Amore Influence of pericytes on capillary endothelial cell growth Am. Rev. Respir. Dis. 140 1989 1129 1131
4. S.E. Bursell, A.C. Clermont, B.T. Kinsley, D.C. Simonson, L.M. Aiello, and H.A. Wolpert Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy Invest. Ophthalmol. Vis. Sci. 37 1996 886 897
5. D.S. Calnek, L. Mazzella, S. Roser, J. Roman, and C.M. Hart Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells Arterioscler. Thromb. Vasc. Biol. 23 2003 52 57
6. E. Cernuda-Morollon, F. Rodriguez-Pascual, P. Klatt, S. Lamas, and D. Perez-Sala PPAR agonists amplify iNOS expression while inhibiting NF-kappaB: implications for mesangial cell activation by cytokines J. Am. Soc. Nephrol. 13 2002 2223 2231
7. U. Chakravarthy, T.A. Gardiner, P. Anderson, D.B. Archer, and E.R. Trimble The effect of endothelin 1 on the retinal microvascular pericyte Microvasc. Res. 43 1992 241 254
8. U. Chakravarthy, A.W. Stitt, J. McNally, J.R. Bailie, E.M. Hoey, and P. Duprex Nitric oxide synthase activity and expression in retinal capillary endothelial cells and pericytes Curr. Eye Res. 14 1995 285 294
9. U. Chakravarthy, R.G. Hayes, A.W. Stitt, E. McAuley, and D.B. Archer Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products Diabetes 47 1998 945 952
10. A. Chawla, Y. Barak, L. Nagy, D. Liao, P. Tontonoz, and R.M. Evans PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation Nat. Med. 7 2001 48 52
11. C.W. Chen, Y.H. Chang, C.J. Tsi, and W.W. Lin Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway J. Immunol. 171 2003 979 988
12. D.H. Cho, Y.J. Choi, S.A. Jo, and I. Jo Nitric oxide production and regulation of endothelial nitric oxide synthase phosphorylation by prolonged treatment with troglitazone: evidence for involvement of PPARgamma-dependent and PPARgamma-independent signaling pathways J. Biol. Chem. 279 2004 2499 2506
13. M. Cukiernik, S. Mukherjee, D. Downey, and S. Chakabarti Heme oxygenase in the retina in diabetes Curr. Eye Res. 27 2003 301 308
14. D. Deng, T. Evans, K. Mukherjee, D. Downey, and S. Chakrabarti Diabetes-induced vascular dysfunction in the retina: role of endothelins Diabetologia 42 1999 1228 1234
15. A. Ding, C.F. Nathan, J. Graycar, R. Derynck, D.J. Stuehr, and S. Srimal Macrophage deactivating factor and transforming growth factors-β1,-β2, and -β3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-γ J. Immunol. 145 1990 940 944
16. Y. Du, M.A. Smith, C.M. Miller, and T.S. Kern Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine J. Neurochem. 80 2002 771 779
17. I.O. Haefliger, A. Zschauer, and D.R. Anderson Relaxation of retinal pericyte contractile tone through the nitric oxide-cyclic guanosine monophosphate pathway Invest. Opthalmol. Vis. Sci. 35 1994 991 997
18. Y. Hattori, S. Hattori, and K. Kasai Troglitazone upregulates nitric oxide synthesis in vascular smooth muscle cells Hypertension 33 1999 943 948
19. S. Higashi, A.C. Clermont, V. Dhir, and S.E. Bursell Reversibility of retinal flow abnormalities is disease-duration dependent in diabetic rats Diabetes 47 1998 653 659
20. M.J. Hogan, and L.J. Feeney The Ultrastructure of the retinal vessels. II. The small vessels Ultrastruct. Res. 49 1963 29 46
21. T.S. Kern, and R.L. Engerman Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin Diabetes 50 2001 1636 1642
22. T.S. Kern, J. Tang, M. Mizutani, R.A. Kowluru, R.H. Nagaraj, G. Romeo, F. Podesta, and M. Lorenzi Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia Invest. Ophthalmol. Vis. Sci. 41 2000 3972 3978
23. J. Kim, K.S. Kim, J.W. Shinn, Y.S. Oh, H.T. Kim, I. Jo, and S.H. Shinn The effect of antioxidants on glycated albumin-induced cytotoxicity in bovine retinal pericytes Biochem. Biophys. Res. Commun. 292 2002 1010 1016
24. S. Konno, G.T. Feke, A. Yoshida, N. Fujio, D.G. Goger, and S.M. Buzney Retinal blood flow changes in type I diabetes. A long-term follow-up study Invest. Ophthalmol. Vis. Sci. 37 1996 1140 1148
25. R.A. Kowluru Retinal metabolic abnormalities in diabetic mouse: comparison with diabetic rat Curr. Eye Res. 24 2002 123 128
26. M. Li, G. Pascual, and C.K. Glass Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene Mol. Cell Biol. 20 2000 4699 4707
27. T. Matsugi, Q. Chen, and D.R. Anderson Adenosine-induced relaxation of cultured bovine retinal pericytes Invest. Ophthalmol. Vis. Sci. 38 1997 2695 2701
28. 2-induced relaxation of bovine retinal pericytes by angiotensin II Invest. Ophthalmol. Vis. Sci. 38 1997 652 657
29. D.E. Moller, and D.A. Greene Peroxisome proliferator-activated receptor (PPAR)gamma agonists for diabetes Adv. Prot. Chem. (Drug Discov.) 56 2001 181 212
30. J.Y. Park, N. Takahara, A. Gabriele, E. Chou, K. Naruse, K. Suzuma, T. Yamauchi, S.W. Ha, M. Meier, C.J. Rhodes, and G.L. King Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation Diabetes 49 2000 1239 1248
31. R.G. Petty, and J.D. Pearson Endothelium - the axis of vascular health and disease J. R. Coll. Physicians Lond. 23 1989 92 102
32. M. Ricote, A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation Nature 391 1998 879 882
33. I.P. Salt, V.A. Morrow, F.M. Brandie, J.M. Connell, and J.R. Petrie High glucose inhibits insulin-stimulated nitric oxide production without reducing endothelial nitric-oxide synthase Ser1177 phosphorylation in human aortic endothelial cells J. Biol. Chem. 278 2003 18791 18797
34. D. Shepro, and N.M. Morel Pericyte physiology FASEB J. 7 1993 1031 1038
35. D.E. Sims The pericyte - a review Tissue Cell 18 1986 153 174
36. D.E. Sims Recent advances in pericyte biology. Implications for health and disease Can. J. Cardiol. 7 1991 431 443
37. R.G. Tilton Capillary pericytes: perspectives and future trends J. Electron Microsc. Tech. 19 1991 327 344
38. R.G. Tilton, E.J. Miller, C. Kilo, and J.R. Williamson Pericyte form and distribution in rat retinal and uveal capillaries Invest. Ophthalmol. Vis. Sci. 26 1985 68 73
39. R. Van der Zee, T. Murohara, Z. Luo, F. Zollmann, J. Passeri, C. Lekutat, and J.M. Isner Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium Circulation 95 1997 1030 1037
40. Y. Vodovotz, C. Bogdan, J. Paik, Q.W. Xie, and C. Nathan Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta J. Exp. Med. 178 1993 605 613
41. K.J. Way, N. Katai, and G.L. King Protein kinase C and the development of diabetic vascular complications Diabet. Med. 18 2001 945 959
42. T.M. Willson, P.J. Brown, D.D. Sternbach, and B.R. Henke The PPARs: from orphan receptors to drug discovery J. Med. Chem. 43 2000 527 550
43. H.M. Wright, C.B. Clish, T. Mikami, S. Hauser, K. Yanagi, R. Hiramatsu, C.N. Serhan, and B.M. Spiegelman A synthetic antagonist for the peroxisome proliferator-activated receptor-gamma inhibits adipocyte differentiation J. Biol. Chem. 275 2000 1873 1877
44. T. Zander, J.A. Kraus, C. Grommes, U. Schlegel, D. Feinstein, T. Klockgether, G. Landreth, J. Koenigsknecht, and M.T. Heneka Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARgamma J. Neurochem. 81 2002 1052 1060